Deligoz Bildaci Yelda, Korucu Berfu, Erbay Efe, Erbay Ege, Vural Akif, Caylan Saime Betul, Yigitbasi Barkın, Oktan Mehmet Asi, Colak Ayse, Cavdar Caner, Deger Serpil Muge
Department of Nephrology, Faculty of Medicine, Dokuz Eylul University, Izmir, Türkiye.
Department of Internal Medicine, Faculty of Medicine, Dokuz Eylul University, Izmir, Türkiye.
Artif Organs. 2025 May;49(5):894-899. doi: 10.1111/aor.14948. Epub 2025 Jan 16.
Removing uremic toxins from the body is one of the most critical points in the maintenance hemodialysis (MHD) population. This study aimed to evaluate the effects of medium cutoff (MCO) membranes on pulse wave velocity (PWV) and augmentation index (AIx), early markers of arterial stiffness, in MHD patients over both short- and long-term periods.
Twenty MHD patients were included in this study. Patients were switched from low-flux to MCO membranes. Hemodynamic parameters and laboratory results were recorded in the low-flux membrane as baseline and the second week and the sixth month after switching to the MCO membranes. PWV and AIx were measured using the IME Mobil-O-Graph.
The median was 69.5 years old, with 60% female predominance. 35% of the patients were diabetic, 70% had hypertension, and 21.1% were smokers. The median systolic, diastolic blood pressure, mean arterial pressure, and pulse were similar at all study time points. The pulse pressure tended to decrease with a significant reduction in the sixth month (p = 0.73 and p = 0.03). We did not observe any significant differences regarding the PWV measurements (p = 0.71 and p = 0.62) and total vascular resistance (p = 0.23 and p = 0.79). The median AIx decreased during the study time points, with a significant difference between the second-week MCO and the sixth-month MCO measurements (p = 0.04).
Our findings underscore the potential benefits of MCO membranes to provide a favorable cardiovascular profile in conventional HD setting.
清除体内的尿毒症毒素是维持性血液透析(MHD)患者治疗中的关键环节之一。本研究旨在评估中截流(MCO)膜对MHD患者短期和长期脉搏波速度(PWV)和增强指数(AIx)这两个动脉僵硬度早期指标的影响。
本研究纳入了20例MHD患者。患者从低通量膜转换为MCO膜。在低通量膜时记录血流动力学参数和实验室结果作为基线,并在转换为MCO膜后的第二周和第六个月进行记录。使用IME Mobil-O-Graph测量PWV和AIx。
患者年龄中位数为69.5岁,女性占比60%。35%的患者患有糖尿病,70%患有高血压,21.1%为吸烟者。在所有研究时间点,收缩压、舒张压、平均动脉压和脉搏的中位数相似。脉压有下降趋势,在第六个月有显著降低(p = 0.73和p = 0.03)。我们未观察到PWV测量值(p = 0.71和p = 0.62)和总血管阻力(p = 0.23和p = 0.79)有任何显著差异。在研究时间点期间,AIx中位数下降,在第二周MCO测量值和第六个月MCO测量值之间存在显著差异(p = 0.04)。
我们的研究结果强调了MCO膜在传统血液透析环境中提供有利心血管状况的潜在益处。